Daily SPAC Update – May 21, 2024

by | May 21, 2024

GGAAF + MindMaze Deal Vote. DIST + Youlife Deal Announced. BFAC, IVCB Extension Votes. GODN Sets Deal Vote. INAQ, GLST, PLMI Set Extension Votes.

Boardroom Alpha SPAC Resources
– Full SPAC Listing
– SPAC SEC Filings
– Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

SPAC DEALS ANNOUNCED
DIST + Youlife International Holdings Inc.

MERGER VOTES
GGAAF + MindMaze Group SA

EXTENSION VOTES
BFAC – BATTERY FUTURE ACQUISITION CORP * vote May 17, 2024 -> extend from June 17, 2024 to June 17, 2025
IVCB – INVESTCORP EUROPE ACQUISITION CORP I * vote May 21, 2024 -> extend to December 17, 2024

SPAC DEAL & EXTENSION VOTES SET
GODN – Golden Star Acquisition Corp * DEAL VOTE SET: May 30, 2024 * trust $10.73
INAQ – Insight Acquisition Corp * EXTENSION VOTE SET: Jun 07, 2024 * trust $11.96
GLST – Global Star Acquisition Inc * EXTENSION VOTE SET: Jun 11, 2024 * trust $11.12
PLMI – Plum Acquisition Corp I * EXTENSION VOTE SET: Jun 14, 2024 * trust $11.17

OTHER SPAC NEWS
CNDA – CONCORD ACQUISITION CORP II * Non-Binding LOI
PWUP – POWERUP ACQUISITION CORP * Vote Delayed

YESTERDAY’S TOP SPAC GAINERS
9.08% ~ $ 9.25 | SEPA – SEP ACQUISITION CORP (Announced)
6.41% ~ $ 11.79 | ATMC – ALPHATIME ACQUISITION CORP (Announced)
4.14% ~ $ 11.71 | CBRG – Chain Bridge I (Pre-Deal)
2.46% ~ $ 7.50 | DECA – Denali Capital Acquisition Corp. (Announced)

YESTERDAY’S TOP SPAC LOSERS
-12.28% ~ $ 9.86 | USCT – TKB Critical Technologies 1 (Pre-Deal)
-8.62% ~ $ 10.18 | SCRM – Screaming Eagle Acquisition Corp. (Announced)
-7.51% ~ $ 10.96 | FHLT – Future Health ESG Corp. (Pre-Deal)
-5.75% ~ $ 11.31 | AEAE – AltEnergy Acquisition Corp (Announced)
-4.69% ~ $ 12.00 | HUDA – Hudson Acquisition I Corp. (Pre-Deal)

Recent Analysis

CEO & CFO Moves Review (Sept 6)

This week’s moves include CEO and CFO changes include moves at Accuray Inc. (ARAY), Atlassian Corporation (TEAM), Azenta Inc. (AZTA), Bloomin’ Brands, Inc. (BLMN), Chipotle Mexican Grill, Inc. (CMG), Fossil Group, Inc. (FOSL), NovoCure Limited (NVCR), and Repligen Corporation (RGEN).

Daily SPAC Update – September 6, 2024

CDAQ + EEW Renewables and EVGR + Forekast Deals Announced. Vine Hill (VCIC) and Andretti (POLE) $200M SPAC IPOs. PPHP Extension Approved. XFIN Deal Vote Set.

Daily SPAC Update – September 5, 2024

KVAC + Medera Deal Announced. IRAA Extension Vote. ACAB and RFAC Set Extension Votes. Merger Agreements for DECA, CCTS and ACAB Amendment. CLOE Vote Postponed (again).

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.